dātma - About the company
dātma is a seed company based in Beaverton (United States), founded in 2016 by Christopher Corless and Ganapati Srinivasa. It operates as a Provider of software to clinics for decision-making and omics data automation. dātma has raised $2.5M in funding. The company has 162 active competitors, including 41 funded and 8 that have exited. Its top competitors include companies like Cellworks, Life Bit and IMU Biosciences.
Company Details
Provider of software to clinics for decision-making and omics data automation. The company offers tools for data harmonization, visualization, sharing, and analysis to enable precision medicine from research to the clinic. The company's products include dātma.BASE, dātma.360, dātma.FED, and more.
- Website
- www.datma.com/
- Email ID
- *****@datma.com
- Registered Address
- 15/3 (8/3), AnandaPuram, Abiramapuram, Mylapore Chennai 600004, Chennai, Chennai, Tamil Nadu, India, 600004
Key Metrics
Founded Year
2016
Location
Beaverton, United States
Stage
Seed
Total Funding
$2.5M in 4 rounds
Latest Funding Round
Investors
Ranked
17th among 162 active competitors
Employee Count
39 as on Aug 31, 2026
Legal entities associated with dātma
dātma is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
DATMA INDIA PRIVATE LIMITED CIN: U72900TN2022FTC149825 , India, Active | Feb 10, 2022 | 0 - ₹10 Cr (As on Mar 31, 2025) | - |
Sign up to download dātma's company profile
dātma's funding and investors
dātma has raised a total funding of $2.5M over 4 rounds. Its first funding round was on Jul 01, 2017. dātma has 2 institutional investors.
Here is the list of recent funding rounds of dātma:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 17, 2024 | 3028173 | Seed | 3741568 | 6280290 | 7399227 | 6827615 |
Feb 19, 2019 | 5060256 | Grant (prize money) | 9022068 | 3779794 | 1660014 | |
Aug 15, 2018 | 2594083 | Grant (prize money) | 8967897 | 2657101 | 9826107 |
Access funding benchmarks and valuations. Sign up today!View details of dātma's funding rounds and investors
dātma's founders and board of directors
Founder? Claim ProfileThe founders of dātma are Christopher Corless and Ganapati Srinivasa.
Here are the details of dātma's key team members:
- Christopher Corless: Co-Founder of dātma and founder of 1 other company. Contact Info: 2 email addresses
- Ganapati Srinivasa: Founder of dātma and founder of 1 other company. Contact Info: 2 email addresses
View details of dātma's Founder profiles and Board Members
dātma's employee count trend
dātma has 39 employees as of Aug 26. Here is dātma's employee count trend over the years:
Uncover dātma's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
dātma's Competitors and alternates
Top competitors of dātma include Cellworks, Life Bit and IMU Biosciences. Here is the list of Top 10 competitors of dātma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Cellworks 2005, San Jose (United States), Series B | Developer of a biosimulation platform | $16.5M | 66/100 | |
2nd | Life Bit 2017, London (United Kingdom), Series B | AI and SaaS-based genomics analysis software for drug development | $70.9M | 57/100 | |
3rd |  IMU Biosciences 2019, London (United Kingdom), Series A | Provider of immune discovery platform for precision medicines | $53M | 56/100 | |
4th | Provider of bioinformatic platforms for health management and drug development | $366M | 55/100 | ||
5th | BAMF Health 2018, Grand Rapids (United States), Series C | Developer of AI-enabled molecular imaging and theranostics | $63.7M | 55/100 | |
6th | Biostate 2023, Houston (United States), Series A | Developer of generative AI based RNAstate research platform to predict future omics states | $16M | 54/100 | |
7th |  Omega Therapeutics 2016, Cambridge (United States), Public | Provider of platform for human genome study for precision medicine | $211M | 52/100 | |
8th | Provider of an AI-enabled immunotherapy based tumor diagnostic platform | $38.2M | 51/100 | ||
9th |  Liquid Biosciences 2017, Aliso Viejo (United States), Series C | Provider of bio-analytics platform to identify the biological and behavioral truth driving patient outcomes | $40.1M | - | 51/100 |
10th |  Watershed 2019, Sacramento (United States), Series A | Provider of software solution for biological data analysis, discovery, and collaboration | $19.7M | 48/100 | |
17th |  dātma 2016, Beaverton (United States), Seed | Provider of software to clinics for decision-making and omics data automation | $2.5M | 42/100 |
_1568349958328.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on dātma's competitors? Click here to see the top ones
dātma's Investments and acquisitions
dātma has made no investments or acquisitions yet.
Reports related to dātma
Here is the latest report on dātma's sector:
News related to dātma
•
datma Launches Advanced Patient Journey Mapping in Federated Real-World Data PlatformHIT Consultant•May 06, 2025•dātma
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about dātma
Explore our recently published companies
- Premier Algarve - Faro based, 2017 founded, Unfunded company
- Recent World News - Unfunded company
- Carvocity - Gilbert based, 2016 founded, Unfunded company
- tecpert - Germany based, Public company
- Munro Strategic Perspective - Windsor based, Unfunded company
- RJ Handyman Services - Unfunded company
